Changeflow GovPing Healthcare & Life Sciences USPTO Trademark Application - Clinical Diagnost...
Routine Notice Added Final

USPTO Trademark Application - Clinical Diagnostic Reagents

Favicon for changeflow.com USPTO Trademarks - Pharmaceuticals (Class 005)
Published
Detected
Email

Summary

The USPTO has received an intent-to-use trademark application (TM99492783) for clinical diagnostic reagents and related medical imaging agents. The application was filed on November 12, 2025, with an effective date of March 22, 2026.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The United States Patent and Trademark Office (USPTO) has recorded an intent-to-use trademark application, TM99492783, for goods including clinical diagnostic reagents, contrast media for medical imaging, diagnostic agents, imaging agents for MRI, surgical dyes, and radiopharmaceutical preparations. The application was filed on November 12, 2025, and is associated with Class 005, which typically covers pharmaceuticals and veterinary preparations.

This filing indicates a future intent to use the trademark for these specific goods. While this is a trademark application and not a regulatory filing with direct compliance obligations, it signals potential market activity in the pharmaceutical and medical device sectors. Companies involved in the development, manufacturing, or distribution of these products should be aware of new trademark filings that may impact their own branding or product launches.

Archived snapshot

Mar 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Trademark Applications

Trademark 99492783

Intent to Use TM99492783 Kind: intenttouse Mar 22, 2026

Abstract

clinical diagnostic reagents; contrast media for in vivo imaging; contrast media for use with medical imaging equipment; diagnostic agents for medical use in in vivo scanning; imaging agents for magnetic resonance imaging (MRI); medical imaging contrast media; radio-isotope markers for diagnostic use; radiopharmaceutical agents for use in amyloid pathology detection; radiopharmaceutical imaging and detection agents for diagnosing andmonitoring cancer; radiopharmaceutical preparations for diagnostic purposes; radiopharmaceuticals; surgical dyes; active chemical ingredients for use in the manufacture of pharmaceuticals; carbohydrates used as an ingredient in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of medicines; chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the production of medicines

Filing Date

2025-11-12

View original document →

Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
November 12th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
Trademark 99492783

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Trademark Filing
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!